Merit Medical Financials

MMSI Stock  USD 102.90  0.83  0.81%   
Merit Medical Systems may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. As of now, Merit Medical's Total Current Liabilities is increasing as compared to previous years. The Merit Medical's current Total Stockholder Equity is estimated to increase to about 1.5 B, while Common Stock Shares Outstanding is projected to decrease to under 39.5 M. Key indicators impacting Merit Medical's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.70.67
Sufficiently Up
Slightly volatile
Current Ratio3.386.26
Way Down
Slightly volatile
The financial analysis of Merit Medical is a critical element in measuring its lifeblood. Investors should not minimize Merit Medical's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

114 Million

  

Merit Medical Stock Summary

Merit Medical competes with Teleflex Incorporated, Cooper Companies,, West Pharmaceutical, ICU Medical, and AngioDynamics. Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah. Merit Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 6446 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS5898891040
CUSIP589889104
LocationUtah; U.S.A
Business Address1600 West Merit
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.merit.com
Phone801 253 1600
CurrencyUSD - US Dollar

Merit Medical Key Financial Ratios

Merit Medical Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets1.7B1.6B1.7B2.3B2.7B2.8B
Other Current Liab99.0M148.3M112.2M120.4M138.5M145.4M
Net Debt378.2M247.3M210.3M304.3M350.0M367.5M
Retained Earnings357.8M406.3M480.8M575.2M661.5M694.5M
Net Receivables158.0M172.8M178.4M189.3M217.7M228.5M
Inventory198.0M221.9M266.0M303.9M349.5M366.9M
Other Current Assets16.8M19.7M26.2M26.2M30.1M31.6M
Total Liab705.8M608.5M519.6M1.1B1.3B1.4B
Total Current Assets429.7M482.2M529.1M1.1B1.3B1.3B
Short Term Debt33.3M29.8M33.3M12.1M13.9M10.5M
Intangible Assets367.9M319.3M275.9M325.9M374.8M393.5M
Cash56.9M67.8M58.4M587.0M675.1M708.8M
Accounts Payable49.8M55.6M68.5M65.9M75.8M79.6M
Common Stock606.2M641.5M675.2M638.2M733.9M770.6M
Other Liab120.7M102.7M76.3M52.4M60.3M35.4M
Other Assets28.1M227.7M47.5M31.9M36.7M25.7M
Long Term Debt343.7M234.4M186.8M823.0M946.5M993.8M
Good Will363.5M361.7M359.8M382.2M439.6M461.6M
Net Tangible Assets151.4M227.1M358.8M508.7M585.0M614.3M
Long Term Debt Total432.0M343.7M234.4M186.8M214.8M281.4M

Merit Medical Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense10.0M5.3M6.3M15.5M17.8M18.7M
Total Revenue963.9M1.1B1.2B1.3B1.4B1.5B
Gross Profit401.2M485.3M519.1M583.9M671.5M705.0M
Operating Income(62.6M)60.9M87.6M123.9M142.5M149.7M
Ebit(4.1M)57.7M89.0M130.2M149.7M157.2M
Ebitda102.7M153.5M181.2M231.4M266.2M279.5M
Cost Of Revenue562.7M589.4M631.9M673.5M774.5M813.2M
Income Before Tax(13.2M)53.9M82.6M112.1M128.9M135.3M
Net Income(9.8M)48.5M74.5M94.4M108.6M114.0M
Income Tax Expense(3.4M)5.5M8.1M17.7M20.3M21.3M
Research Development57.5M71.2M75.5M82.7M95.1M99.9M
Tax Provision(3.4M)5.5M8.1M10.6M9.5M10.0M
Interest Income604K769K439K656K590.4K958.0K
Net Interest Income(9.4M)(4.5M)(5.9M)(12.0M)(13.8M)(14.5M)

Merit Medical Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory29.4M(25.2M)(47.9M)(32.1M)(28.9M)(27.4M)
Change In Cash12.6M10.8M(7.2M)528.6M607.9M638.3M
Free Cash Flow116.0M119.3M69.3M108.5M124.7M131.0M
Depreciation106.8M95.8M92.2M101.3M116.5M122.3M
Other Non Cash Items31.0M9.4M15.9M10.8M12.4M13.0M
Capital Expenditures49.3M27.9M45.0M36.7M42.2M29.4M
Net Income(9.8M)48.5M74.5M94.4M108.6M114.0M
End Period Cash Flow56.9M67.8M60.6M589.1M677.5M711.4M
Change To Netincome22.8M175.1M20.8M39.8M45.7M30.8M
Investments250K(37.2M)(57.4M)(184.3M)(165.9M)(157.6M)
Net Borrowings44.5M(88.4M)(108.5M)(44.9M)(40.4M)(38.4M)

Merit Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Merit Medical's current stock value. Our valuation model uses many indicators to compare Merit Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Merit Medical competition to find correlations between indicators driving Merit Medical's intrinsic value. More Info.
Merit Medical Systems is regarded fifth in return on equity category among its peers. It also is regarded fifth in return on asset category among its peers reporting about  0.49  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Merit Medical Systems is roughly  2.06 . As of now, Merit Medical's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Merit Medical's earnings, one of the primary drivers of an investment's value.

Merit Medical Systems Systematic Risk

Merit Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Merit Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Merit Medical Systems correlated with the market. If Beta is less than 0 Merit Medical generally moves in the opposite direction as compared to the market. If Merit Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Merit Medical Systems is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Merit Medical is generally in the same direction as the market. If Beta > 1 Merit Medical moves generally in the same direction as, but more than the movement of the benchmark.

Merit Medical Thematic Clasifications

Merit Medical Systems is part of several thematic ideas from Health Management to Office Supplies. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Merit Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Merit Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Merit Medical growth as a starting point in their analysis.

Price Earnings To Growth Ratio

1.74

As of now, Merit Medical's Price Earnings To Growth Ratio is increasing as compared to previous years.

Merit Medical January 18, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Merit Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Merit Medical Systems. We use our internally-developed statistical techniques to arrive at the intrinsic value of Merit Medical Systems based on widely used predictive technical indicators. In general, we focus on analyzing Merit Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Merit Medical's daily price indicators and compare them against related drivers.

Complementary Tools for Merit Stock analysis

When running Merit Medical's price analysis, check to measure Merit Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merit Medical is operating at the current time. Most of Merit Medical's value examination focuses on studying past and present price action to predict the probability of Merit Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merit Medical's price. Additionally, you may evaluate how the addition of Merit Medical to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated